Clinical trial · Interventional
Mobile App for Symptoms Monitoring in Cancer Patients: a Pilot Study
Single Arm Pilot Study on a Mobile App for Symptoms Monitoring in Cancer Patients on Active Treatments
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
With the growing number of cancer survivors, challenges to deal with comorbidities and impacted quality of life of cancer survivors by the disease and treatments also surge. Symptoms and Adverse Events are common and insufficiently monitored in real time / real life, which leads to increased symptom burden, treatment delays and unplanned hospital admissions. Remote monitoring apps have been shown to improve quality of life, symptom control and survival in published clinical trials, but no data with such interventions exists on the Portuguese population. We will conduct a pilot study to explore the feasibility of a mobile app for remote symptom monitoring in cancer patients. Patients will be recruited in Portuguese hospitals and will be invited to test the app for one month. Patient experience and satisfaction will be assessed via a weekly survey. The results of this pilot study will inform subsequent randomized clinical trials to test safety and efficacy of remote monitoring and lifestyle interventions to improve symptoms control and quality of life.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
| Chemotherapeutic Agent Toxicity | — | UNRESOLVED | — |
| Quality of Life | — | UNRESOLVED | — |
| Symptoms and Signs | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Mentora app | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Mentora
- description
- Remote symptoms monitoring with mobile app
- interventionNames
- Device: Mentora app
Primary outcomes (1)
- measure
- Compliance rates with the weekly reports or weekly symptom log on the app higher than 60%% (Acceptability of the MHapp)
- timeFrame
- 1 month
- description
- acceptability of the MHapp, measured by adherence to self-reporting will be assessed at 1 month. The outcome will be considered positive if at least one of the 2 following criteria applies to more than 60% of participants enrolled: replies to 2 or more weekly reports OR at least one weekly log to the app.
Secondary outcomes (6)
- measure
- % of side effects and adverse events reported on medical appointments also registered in the MHapp
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * adults (18 years old or older) * with a cancer diagnosis at any stage of any primary tumor (solid or hematologic) * in systemic oncologic treatments of any type (including but not limited to immunotherapy, chemotherapy and targeted therapies) expected to continue for at least 4 weeks after enrolment, except when single treatment with hormone therapy for prostate cancer or breast cancer * fluent in written Portuguese * with a personal mobile smartphone (android or iphone) * willing to give informed consent for study participation Exclusion criteria: * Cognitive impairment or disability that limits capacity to comply with study interventions and assessments as per attending physician's evaluation * Having a life expectancy \< 3 months as determined by the attending oncologist ECOG performance status greater than 2 * Unable to read and comprehend written portuguese language
References
Publications (0)
Data not yet available